Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Geneviève de Saint-Basile is active.

Publication


Featured researches published by Geneviève de Saint-Basile.


Journal of Experimental Medicine | 2005

Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product

Benoit Pasquier; Luo Yin; Marie-Claude Fondanèche; Francis Relouzat; Coralie Bloch-Queyrat; Nathalie Lambert; Alain Fischer; Geneviève de Saint-Basile; Sylvain Latour

SAP is an adaptor protein expressed in T cells and natural killer cells. It plays a critical role in immunity, as it is mutated in humans with X-linked lymphoproliferative syndrome (XLP), a fatal immunodeficiency characterized by an abnormal response to Epstein-Barr virus (EBV) infection. SAP interacts with the SLAM family receptors and promotes transduction signal events by these receptors through its capacity to recruit and activate the Src kinase FynT. Because it has been previously established that FynT is selectively required for the development of NKT cells, we examined NKT cells in SAP-deficient mice and in humans with XLP. In the absence of SAP, the development of NKT cells is severely impaired both in mice and in humans. These results imply that SAP is a potent regulator of NKT cell development. They also identify for the first time a defect in NKT cells associated with a human primary immunodeficiency, revealing a potential role of NKT cells in the immune response to EBV.


PLOS ONE | 2012

Inherited MST1 deficiency underlies susceptibility to EV-HPV infections.

Amandine Crequer; Capucine Picard; Etienne Patin; Aurelia D’Amico; Avinash Abhyankar; Martine Munzer; Marianne Debré; Shen-Ying Zhang; Geneviève de Saint-Basile; Alain Fischer; Laurent Abel; Gérard Orth; Jean-Laurent Casanova; Emmanuelle Jouanguy

Epidermodysplasia verruciformis (EV) is characterized by persistent cutaneous lesions caused by a specific group of related human papillomavirus genotypes (EV-HPVs) in otherwise healthy individuals. Autosomal recessive (AR) EVER1 and EVER2 deficiencies account for two thirds of known cases of EV. AR RHOH deficiency has recently been described in two siblings with EV-HPV infections as well as other infectious and tumoral manifestations. We report here the whole-exome based discovery of AR MST1 deficiency in a 19-year-old patient with a T-cell deficiency associated with EV-HPV, bacterial and fungal infections. MST1 deficiency has recently been described in seven patients from three unrelated kindreds with profound T-cell deficiency and various viral and bacterial infections. The patient was also homozygous for a rare ERCC3 variation. Our findings broaden the clinical range of infections seen in MST1 deficiency and provide a new genetic etiology of susceptibility to EV-HPV infections. Together with the recent discovery of RHOH deficiency, they suggest that T cells are involved in the control of EV-HPVs, at least in some individuals.


Blood | 2011

Control of Plasmodium falciparum erythrocytic cycle : gamma-delta T cells target the red blood cell-invasive merozoites

Giulia Costa; Séverine Loizon; Marianne Guenot; Iulia Mocan; Franck Halary; Geneviève de Saint-Basile; Vincent Pitard; Julie Déchanet-Merville; Jean-François Moreau; Marita Troye-Blomberg; Odile Mercereau-Puijalon; Charlotte Behr

The control of Plasmodium falciparum erythrocytic parasite density is essential for protection against malaria, because it prevents pathogenesis and progression toward severe disease. P falciparum blood-stage parasite cultures are inhibited by human Vγ9Vδ2 γδ T cells, but the underlying mechanism remains poorly understood. Here, we show that both intraerythrocytic parasites and the extracellular red blood cell-invasive merozoites specifically activate Vγ9Vδ2 T cells in a γδ T cell receptor-dependent manner and trigger their degranulation. In contrast, the γδ T cell-mediated antiparasitic activity only targets the extracellular merozoites. Using perforin-deficient and granulysin-silenced T-cell lines, we demonstrate that granulysin is essential for the in vitro antiplasmodial process, whereas perforin is dispensable. Patients infected with P falciparum exhibited elevated granulysin plasma levels associated with high levels of granulysin-expressing Vδ2(+) T cells endowed with parasite-specific degranulation capacity. This indicates in vivo activation of Vγ9Vδ2 T cells along with granulysin triggering and discharge during primary acute falciparum malaria. Altogether, this work identifies Vγ9Vδ2 T cells as unconventional immune effectors targeting the red blood cell-invasive extracellular P falciparum merozoites and opens novel perspectives for immune interventions harnessing the antiparasitic activity of Vγ9Vδ2 T cells to control parasite density in malaria patients.


Blood | 2013

Characteristics and outcome of early-onset, severe forms of Wiskott-Aldrich syndrome

Nizar Mahlaoui; Isabelle Pellier; Cécile Mignot; Jean-Philippe Jais; Chrystèle Bilhou-Nabera; Despina Moshous; Bénédicte Neven; Capucine Picard; Geneviève de Saint-Basile; Marina Cavazzana-Calvo; Stéphane Blanche; Alain Fischer

On the basis of a nationwide database of 160 patients with Wiskott-Aldrich syndrome (WAS), we identified a subset of infants who were significantly more likely to be attributed with an Ochs score of 5 before the age of 2 (n = 26 of 47 [55%], P = 2.8 × 10(−7)). A retrospective analysis revealed that these patients often had severe refractory thrombocytopenia (n = 13), autoimmune hemolytic anemia (n = 15), and vasculitis (n = 6). One patient had developed 2 distinct cancers. Hemizygous mutations predictive of the absence of WAS protein were identified in 19 of the 24 tested patients, and the absence of WAS protein was confirmed in all 10 investigated cases. Allogeneic hematopoietic stem cell transplantation (HSCT) was found to be a curative treatment with a relatively good prognosis because it was successful in 17 of 22 patients. Nevertheless, 3 patients experienced significant disease sequelae and 4 patients died before HSCT. Therefore, the present study identifies a distinct subgroup of WAS patients with early-onset, life-threatening manifestations. We suggest that HSCT is a curative strategy in this subgroup of patients and should be performed as early in life as possible, even when a fully matched donor is lacking.


Journal of Clinical Immunology | 2004

Griscelli Syndrome: Characterization of a New Mutation and Rescue of T-Cytotoxic Activity by Retroviral Transfer of RAB27A Gene

João C. S. Bizario; Jérôme Feldmann; Fabíola Attié de Castro; Gaël Ménasché; Cristina Miuki Abe Jacob; Lilian Maria Cristofani; Erasmo Barbante Casella; Júlio C. Voltarelli; Geneviève de Saint-Basile; Enilza M. Espreafico

Griscelli syndrome (GS) is caused by mutations in the MYO5A (GS1), RAB27A (GS2), or MLPH (GS3) genes, all of which lead to a similar pigmentary dilution. In addition, GS1 patients show primary neurological impairment, whereas GS2 patients present immunodeficiency and periods of lymphocyte proliferation and activation, leading to their infiltration in many organs, such as the nervous system, causing secondary neurological damage. We report the diagnosis of GS2 in a 4-year-old child with haemophagocytic syndrome, immunodeficiency, and secondary neurological disorders. Typical melanosome accumulation was found in skin melanocytes and pigment clumps were observed in hair shafts. Two heterozygous mutant alleles of the RAB27A gene were found, a C-T transition (C352T) that leads to Q118stop and a G-C transversion on the exon 5 splicing donor site (G467+1C). Functional assays showed increased cellular activation and decreased cytotoxic activity of NK and CD8+ T cells, associated with defective lytic granules release. Myosin-Va expression and localization in the patient lymphocytes were also analyzed. Most importantly, we show that cytotoxic activity of the patients CD8+ T lymphocytes can be rescued in vitro by RAB27A gene transfer mediated by a recombinant retroviral vector, a first step towards a potential treatment of the acute phase of GS2 by RAB27A transduced lymphocytes.


The American Journal of Surgical Pathology | 2008

Chronic active gastritis in X-linked lymphoproliferative disease

Anne-Laure Rougemont; Jean-Christophe Fournet; Steven R. Martin; Geneviève de Saint-Basile; Sylvain Latour; Marie-Noël Primeau; Laura Rubbia-Brandt; Elie Haddad; Françoise Le Deist

Gastric lesions in primary constitutive immune deficiencies include multifocal atrophic gastritis, erosive pangastritis, and a pattern of gastric lesions reminiscent of graft-versus-host disease. We describe the genetic anomalies in 2 monozygotic twins with an X-linked lymphoproliferative disease (XLP; MIM 308240), a rare familial setting of high susceptibility to Epstein-Barr virus (EBV). Since early childhood, both twin brothers exhibited a severe chronic active atrophic pangastritis. A germline screening of the SH2D1A (MIM 300490) and BIRC4 (MIM 300079) genes was performed, and also a high-resolution whole-genome SNP profiling (Infinium Sentrix Human-1 Genotyping BeadChip, Illumina). A 3 Megabase deletion in the Xq25 region, encompassing the SH2D1A gene, was defined by SNP array genotyping. Histologic analysis of yearly or twice yearly gastric biopsies in both children showed a Helicobacter pylori-negative, Epstein-Barr virus-negative chronic active atrophic pangastritis, with superficial ulcer formation, foveolar hyperplasia, glandular dilatation and ultimately pseudopyloric and intestinal metaplasia. No such chronic active inflammatory gastric lesions have been reported to date in XLP. The similarities between XLP and common variable immunodeficiency (MIM 240500) underscore the need for early recognition and close monitoring of these gastric lesions, with special regard to their neoplastic potential. No infectious cause was determined. We favor a dysimmune mechanism in the development of this chronic atrophic gastritis, presenting a striking similarity to the recently described atrophic autoimmune pangastritis.


Clinical Case Reports | 2017

Late‐onset hemophagocytic lymphohistiocytosis with neurological presentation

Sarah Benezech; Thierry Walzer; Emily Charrier; Damien Heidelberg; Geneviève de Saint-Basile; Yves Bertrand; Alexandre Belot

Missense mutations in genes involved in familial hemophagocytic lymphohistiocytosis can delay the onset of this life‐threatening disease. In children and adults, early recognition of aspecific features as neurological symptoms is crucial as urgent treatment is required.


Journal of Cell Biology | 2001

Rab27a: A Key to Melanosome Transport in Human Melanocytes

Philippe Bahadoran; Edith Aberdam; F. Mantoux; Roser Buscà; Karine Bille; Nevin Yalman; Geneviève de Saint-Basile; Ricardo Casaroli-Marano; Jean-Paul Ortonne; Robert Ballotti


Journal of Cell Biology | 1998

Deficient Peptide Loading and MHC Class II Endosomal Sorting in a Human Genetic Immunodeficiency Disease: the Chediak-Higashi Syndrome

Wolfgang Faigle; Graça Raposo; Danièle Tenza; Valérie Pinet; Anne B. Vogt; Harald Kropshofer; Alain Fischer; Geneviève de Saint-Basile; Sebastian Amigorena


Blood | 2007

Perforin-dependent apoptosis functionally compensates Fas deficiency in activation-induced cell death of human T lymphocytes.

Véronique Mateo; Michael Ménager; Geneviève de Saint-Basile; Marie-Claude Stolzenberg; Bertrand Roquelaure; Nicolas André; Benoit Florkin; Françoise Le Deist; Capucine Picard; Alain Fischer; Frédéric Rieux-Laucat

Collaboration


Dive into the Geneviève de Saint-Basile's collaboration.

Top Co-Authors

Avatar

Alain Fischer

Necker-Enfants Malades Hospital

View shared research outputs
Top Co-Authors

Avatar

Marina Cavazzana-Calvo

Necker-Enfants Malades Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Capucine Picard

Paris Descartes University

View shared research outputs
Top Co-Authors

Avatar

Stéphane Blanche

Paris Descartes University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge